Friday 6 November 2026
Export CL’s income statement to Excel — free account
Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
96.89
1.80
−1.82%
Follow CL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 8 |
| 469.09% | 342.58% | 251.92% | 218.74% | ||
| 13.17% | 12.56% | 11.90% | 11.99% | ||
ROIC |
29.25% | 28.02% | 27.74% | 28.91% | |
Return on Tangible Assets |
60.64% | 43.77% | 42.47% | 47.43% | |
Average Days of Receivables |
30.00 | 33.16 | 34.03 | 32.60 | |
Free Cash Flow per Share |
4.49 | 4.70 | 4.83 | 4.75 | |
Free Cash Flow |
3,634.00 | 3,767.00 | 3,858.00 | 3,789.00 | |
Capital Expenditures |
(564.00) | (578.00) | (598.00) | (577.00) | |
| Other line items | |||||
Cash ROIC |
37.69% | 38.46% | 39.40% | 38.34% | |
Accounts Receivable Turnover |
12.75 | 11.51 | 11.27 | 11.48 | |
Accounts Payable Turnover |
4.18 | 4.26 | 4.27 | 4.23 | |
Inventory Turnover |
4.05 | 3.94 | 3.87 | 3.91 | |
Average Days of Payables |
93.78 | 92.12 | 92.69 | 91.26 | |
Days of Inventory on Hand |
91.22 | 91.68 | 95.58 | 95.01 | |
Tax Rate |
(0.26) | (0.26) | (0.26) | (0.27) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
38.77% | 38.86% | 39.19% | 39.41% | |
Share Based Compensation of Revenue |
0.76% | 0.83% | 0.85% | 0.79% | |
Interest Coverage |
12.38 | 12.14 | 12.32 | 12.69 | |
Operating CF/Net income |
1.97 | 2.08 | 2.19 | 2.13 | |
Depreciation/Fixed assets |
0.33 | 0.34 | 0.34 | 0.34 | |
Capex/Depreciation |
(0.36) | (0.37) | (0.38) | (0.37) | |
Revenue per Share |
25.20 | 25.92 | 26.33 | 26.71 | |
Operating CF per Share |
5.19 | 5.42 | 5.57 | 5.48 | |
Capex per Share |
(0.70) | (0.72) | (0.75) | (0.72) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 3 Nov 2026